Ownership history in Crossmark Global Holdings, Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which Crossmark Global Holdings, Inc. reported a position in VERONA PHARMA PLC SPONSORED AD (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 14,068 | +1,932 | +15.9% | 0.02% | $1.5M | — |
| 2025 Q2 | REDUCED | 12,136 | -4,209 | -25.8% | 0.02% | $1.1M | — |
| 2025 Q1 | ADDED | 16,345 | +100 | +0.6% | 0.02% | $1.0M | — |
| 2024 Q4 | ADDED | 16,245 | +95 | +0.6% | 0.01% | $754K | — |
As of 2025 Q3 — sorted by position size